ALPS Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.62M | Buy |
162,820
+4,623
| +3% | +$110K | 0.02% | 303 |
|
|
2025
Q4 | $4.23M | Buy |
158,197
+58,383
| +58% | +$1.4M | 0.02% | 269 |
|
|
2025
Q3 | $2.13M | Sell |
99,814
-12,081
| -11% | -$286K | 0.01% | 367 |
|
|
2025
Q2 | $2.41M | Sell |
111,895
-28,330
| -20% | -$527K | 0.01% | 338 |
|
|
2025
Q1 | $2.33M | Buy |
140,225
+5,681
| +4% | +$103K | 0.01% | 330 |
|
|
2024
Q4 | $2.47M | Buy |
134,544
+7,448
| +6% | +$120K | 0.02% | 316 |
|
|
2024
Q3 | $1.95M | Sell |
127,096
-1,770
| -1% | -$29.5K | 0.01% | 364 |
|
|
2024
Q2 | $2.09M | Buy |
128,866
+12,644
| +11% | +$204K | 0.01% | 329 |
|
|
2024
Q1 | $2.15M | Buy |
116,222
+4,489
| +4% | +$111K | 0.02% | 337 |
|
|
2023
Q4 | $3.5M | Sell |
111,733
-9,077
| -8% | -$217K | 0.03% | 260 |
|
|
2023
Q3 | $2.52M | Buy |
120,810
+1,274
| +1% | +$34.6K | 0.02% | 290 |
|
|
2023
Q2 | $2.86M | Buy |
119,536
+12,653
| +12% | +$281K | 0.02% | 254 |
|
|
2023
Q1 | $2.01M | Sell |
106,883
-2,821
| -3% | -$53.7K | 0.02% | 289 |
|
|
2022
Q4 | $1.75M | Buy |
109,704
+21,338
| +24% | +$334K | 0.02% | 322 |
|
|
2022
Q3 | $1.45M | Sell |
88,366
-6,118
| -6% | -$99.1K | 0.01% | 367 |
|
|
2022
Q2 | $1.33M | Sell |
94,484
-71,197
| -43% | -$1.33M | 0.01% | 401 |
|
|
2022
Q1 | $4.01M | Sell |
165,681
-20,363
| -11% | -$493K | 0.04% | 142 |
|
|
2021
Q4 | $4.34M | Sell |
186,044
-10,850
| -6% | -$218K | 0.05% | 159 |
|
|
2021
Q3 | $3.27M | Sell |
196,894
-13,285
| -6% | -$256K | 0.03% | 206 |
|
|
2021
Q2 | $5.13M | Buy |
+210,179
| New | +$4.74M | 0.05% | 175 |
|
|
2019
Q4 | – | Sell |
-211,163
| Closed | -$7.6M | – | 814 |
|
|
2019
Q3 | $7.6M | Sell |
211,163
-89,587
| -30% | -$2.72M | 0.06% | 122 |
|
|
2019
Q2 | $8.04M | Buy |
+300,750
| New | +$7.68M | 0.06% | 126 |
|
|
2017
Q4 | – | Sell |
-120,544
| Closed | -$4.54M | – | 841 |
|
|
2017
Q3 | $4.54M | Buy |
120,544
+10,381
| +9% | +$338K | 0.03% | 144 |
|
|
2017
Q2 | $3.07M | Buy |
110,163
+5,968
| +6% | +$178K | 0.02% | 161 |
|
|
2017
Q1 | $3.58M | Sell |
104,195
-12,196
| -10% | -$431K | 0.02% | 153 |
|
|
2016
Q4 | $3.36M | Sell |
116,391
-36,267
| -24% | -$959K | 0.02% | 148 |
|
|
2016
Q3 | $4.86M | Buy |
+152,658
| New | +$5.18M | 0.04% | 140 |
|
|
2016
Q1 | – | Sell |
-132,936
| Closed | -$4.74M | – | 622 |
|
|
2015
Q4 | $4.74M | Sell |
132,936
-24,709
| -16% | -$871K | 0.05% | 123 |
|
|
2015
Q3 | $52.1K | Buy |
157,645
+58,112
| +58% | +$2.42M | 0.05% | 111 |
|
|
2015
Q2 | $4.17M | Buy |
99,533
+49,968
| +101% | +$1.93M | 0.04% | 128 |
|
|
2015
Q1 | $1.61M | Buy |
+49,565
| New | +$1.7M | 0.01% | 160 |
|
Other funds holding ACAD
BBA
VPM
RI
VCM
PAI